Transense Technlgy - Director/PDMR Shareholding - acquisition of shares

Transense Technologies

12/03/2025 07:00

RNS Number : 2753A

Transense Technologies PLC

12 March 2025

 

 

12 March 2025

Transense Technologies plc

 

("Transense" or the "Company")

 

Director/PDMR shareholding - acquisition of shares

 

Transense Technologies plc (AIM:TRT), the provider of specialist sensing solutions and measurement systems announces that on 11 March 2025, Nigel Rogers (Executive Chairman) and his wife, Julie Rogers, purchased, in aggregate, 5,000 ordinary shares of 10 pence each in the Company ("Ordinary Shares") at 122.0 pence per share.

Following these purchases, Nigel Rogers' total beneficial shareholding in the Company has increased to 287,500 Ordinary Shares, representing approximately 1.89% of the Company's current shares in issue carrying voting rights.

Further details are provided in the forms below in accordance with the requirements of the UK Market Abuse Regulation.

 

For further information please visit www.transense.com or contact:

Transense Technologies plc
Nigel Rogers (Executive Chairman)
Ryan Maughan (Managing Director)
Melvyn Segal (Chief Financial Officer)
Via Investor Relations
(see below)
Cavendish Capital Market Limited (Nominated Adviser and Broker)
Adrian Hadden / Callum Davidson (Corporate Finance)
Jasper Berry (Sales)
0207 220 0500
Investor Relations
Anice McNamee
Tel: +44 (0)1869 238380
Investor.relations@transense.co.uk

 

Notes to Editors:

Transense is headquartered in Oxfordshire, UK and its shares are traded on AIM, a market operated by the London Stock Exchange (AIM: TRT). The Company develops and supplies advanced sensor technology and measurement solutions used by some of the world's leading companies to improve performance, efficiency, and safety in demanding, mission critical applications. Transense currently operates through two active business segments:

SAWsense - designs, supplies and licences advanced sensor solutions based on proven, patent protected Surface Acoustic Wave (SAW) technology to world leading companies in aerospace, automotive, and industrial machinery (including robotics), enabling improved efficiency and performance of their products. Key customers include GE Aerospace, Parker Meggitt, McLaren Applied, Airbus and several other confidential Tier One automotive, aerospace and industrial machinery suppliers.

Translogik - develops smart, connected commercial vehicle tyre inspection equipment to many of the world's leading tyre suppliers, fleet operators and service centres. Enabling accurate measurement and digital capture of safety-critical tyre condition data, used to reduce operating costs, improve safety and provide audit records for regulatory compliance. Key customers include Bridgestone, Goodyear, Continental and Prometeon (Pirelli), and leading independent providers of vehicle fleet maintenance management software, and a growing list of international territory distribution partners.

 

In addition, Transense earns residual royalty income from Bridgestone iTrack - a tyre monitoring system for off-highway vehicles that was developed by Translogik. The associated sales, support and development infrastructure were sold to Bridgestone Corporation, the world's largest tyre producer, in June 2020, and the intellectual property was licensed exclusively to Bridgestone under a ten-year deal expiring in 2030.

 

Find out more at: https://www.transense.com/

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

 

1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Nigel Rogers
2
Reason for the notification
a)
Position/status
Executive Chairman
b)
Initial notification /Amendment
Initial
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Transense Technologies plc
b)
LEI
2138005N52J6KKQ3EY67
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary Shares of 10 pence each
Identification code
GB00BDHDTH21
b)
Nature of the transaction
Purchase of Ordinary Shares
c)
Price and volume
Price(s)
Volume(s)
122.0pence
2,500
d)
Aggregated information
- Aggregated volume
See above
- Price
e)
Date of the transaction
11 March 2025
f)
Place of the transaction
London Stock Exchange, AIM

 

1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Julie Rogers
2
Reason for the notification
a)
Position/status
Wife of Nigel Rogers, Executive Chairman of Transense Technologies plc
b)
Initial notification /Amendment
Initial
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Transense Technologies plc
b)
LEI
2138005N52J6KKQ3EY67
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary Shares of 10 pence each
Identification code
GB00BDHDTH21
b)
Nature of the transaction
Purchase of Ordinary Shares
c)
Price and volume
Price(s)
Volume(s)
122.0pence
2,500
d)
Aggregated information
- Aggregated volume
See above
- Price
e)
Date of the transaction
11 March 2025
f)
Place of the transaction
London Stock Exchange, AIM

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
DSHGPUWCWUPAPGG